A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Vanderbilt-Ingram Cancer Center
Second Life Therapeutics
European Institute of Oncology
Universidade Federal de Pernambuco
Mitera Hospital
Danatlas Pharmaceuticals Co., Ltd
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Fujian Cancer Hospital